Veristat, a global science-based contract research organization, has acquired SQN Clinical, a data-driven contract research companies in Europe. Veristat expects to strengthen its European presence and biometric services.
“Veristat is growing thanks to our ability to offer our customers specialized solutions that help them achieve success faster,” said Patrick Flanagan, Veristat’s chief executive officer. “With the acquisition of SQN Clinical, we demonstrate our global commitment to the services that are critical to driving clinical development and commercial success. We have a tremendous opportunity to provide flexible concepts with local support in order to master even the most complex challenges in the field of clinical data, which is a benefit for both clients and patients. “